Delivery Order SPE2DB22D1202-SPE2DB25FVFQ4
- Not listed
- The Defense Logistics Agency awarded a delivery order totaling $40,340.72 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider...
- The U.S. Defense Logistics Agency (DLA) awarded a $64,726.44 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,551,030 units of the HIV medication BIKTARVY 50-200-25 mg tablet. The contract has an ultimate completion date of August 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency Troop Support Medical awarded a $18,096.74 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561557367 BIKTARVY 50-200-25 MG TABLET UU 30S to be delivered to a location in Conshohocken, Pennsylvania by July 21, 2023. BIKTARVY is a complete single-tablet regimen for the treatment of human immunodeficiency virus (HIV)-1 infection in adults. As the Defense Logistics Agency is responsible for worldwide logistics...
- The Defense Logistics Agency awarded a $35,728.66 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562179238 BIKTARVY 50-200-25 MG TABLET UU 30S. The contract has a period of performance from September 14, 2023 through September 15, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. BIKTARVY is a prescription medication used to treat human immunodeficiency virus (HIV)-1 in adults. This delivery order was awarded under an...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $5,907.98 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,446.65 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply BIKTARVY 50-200-25 MG TABLET medication. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical...
- The Defense Logistics Agency awarded a $42,687.23 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of July 28, 2025, represents a pediatric HIV treatment medication delivery to support federal medical procurement needs. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $8,000 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561466136 BIKTARVY 50-200-25 MG TABLET UU 30S to be delivered to a location in Conshohocken, Pennsylvania by July 12, 2023. BIKTARVY is a complete single-tablet regimen for the treatment of human immunodeficiency virus (HIV)-1 infection in adults. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency Troop Support Medical awarded a $41,504 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4562163839 BIKTARVY 50-200-25 MG TABLET UU 30S to be delivered to a location in Conshohocken, Pennsylvania by September 14, 2023. BIKTARVY is a complete single-tablet regimen for the treatment of human immunodeficiency virus (HIV)-1 infection in adults. As the Defense Logistics Agency is responsible for worldwide logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $118,909.23 to Amerisourcebergen Drug Corporation for the supply of 4561521647 BIKTARVY 50-200-25 MG TABLET UU 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 17-18, 2023. BIKTARVY is an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection. This delivery order was issued under the DLA's...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFQ4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,656.65 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive, non-set-aside award. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing procurement of critical medications to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains a substantial portfolio of federal contracts with the Defense Logistics Agency covering a wide range of medications and medical supplies. The company's role as a pharmaceutical prime vendor enables it to fulfill diverse medical procurement requirements across multiple therapeutic domains in support of Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 7/25/25 |